Correction of endothelial dysfunction in patients with arterial hypertension

Bull Exp Biol Med. 2011 Jun;151(2):183-5. doi: 10.1007/s10517-011-1284-1.

Abstract

We examined 38 patients (mean age 55.92 ± 1.56 years) with a 3-5-year history of arterial hypertension. The study showed that hypertension is accompanied by endothelial dysfunction and one of its forming factors is activation of the inflammatory response. Highly sensitive diagnostic tests can verify initiation of inflammation in preclinical manifestations. The use of nonsteroidal anti-inflammatory drugs, irrespective of the tropism to cyclooxygenase forms, alleviates manifestations of endothelial dysfunction in patients with arterial hypertension.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Aspirin / pharmacology
  • Aspirin / therapeutic use*
  • Biomarkers / blood
  • C-Reactive Protein / metabolism
  • Celecoxib
  • Cyclooxygenase Inhibitors / pharmacology
  • Cyclooxygenase Inhibitors / therapeutic use*
  • Endothelium, Vascular / diagnostic imaging
  • Endothelium, Vascular / drug effects*
  • Endothelium, Vascular / physiopathology
  • Humans
  • Hypertension / blood
  • Hypertension / drug therapy*
  • Hypertension / pathology
  • Intercellular Adhesion Molecule-1 / blood
  • Middle Aged
  • Pyrazoles / pharmacology
  • Pyrazoles / therapeutic use*
  • Statistics, Nonparametric
  • Sulfonamides / pharmacology
  • Sulfonamides / therapeutic use*
  • Treatment Outcome
  • Ultrasonography
  • Vasodilation

Substances

  • Biomarkers
  • Cyclooxygenase Inhibitors
  • Pyrazoles
  • Sulfonamides
  • Intercellular Adhesion Molecule-1
  • C-Reactive Protein
  • Celecoxib
  • Aspirin